(Q41915142)

14 October 2017

ACE inhibitor potentiation of bradykinin-induced venoconstriction (English)

1 reference

14 October 2017

4

Müller-Esterl W

1 reference

14 October 2017

Hecker M

1

1 reference

14 October 2017

Blaukat A

series ordinal

2

1 reference

14 October 2017

Bara AT

series ordinal

3

1 reference

14 October 2017

Busse R

series ordinal

5

1 reference

14 October 2017

language of work or name

English

0 references

publication date

1 August 1997

1 reference

British Journal of Pharmacology

14 October 2017

1 reference

14 October 2017

121

1 reference

14 October 2017

7

1 reference

14 October 2017

1475-1481

1 reference

Endothelium-mediated vasodilation during ACE inhibition.

14 October 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701281

Molecular responses of endothelial tissue to kinins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701281

Subcellular localization and characterization of nitric oxide synthase(s) in endothelial cells: physiological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701281

Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation: interaction at the receptor level

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701281

Potentiation by aminopeptidase P of blood pressure response to bradykinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701281

Characterization of vascular relaxant factor released from cultured endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701281

Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701281

Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701281

ACE inhibitors are endothelium dependent vasodilators of coronary arteries during submaximal stimulation with bradykinin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701281

7 January 2021

Ligand-induced phosphorylation/dephosphorylation of the endogenous bradykinin B2 receptor from human fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701281

7 January 2021

Differential regulation of angiotensin peptide levels in plasma and kidney of the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701281

7 January 2021

Inhibition of angiotensin converting enzyme and potentiation of bradykinin by retro-inverso analogues of short peptides and sequences related to angiotensin I and bradykinin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701281

7 January 2021

Bradykinin receptors: pharmacological properties and biological roles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701281

7 January 2021

Reaction of serine proteases with substituted isocoumarins: discovery of 3,4-dichloroisocoumarin, a new general mechanism based serine protease inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701281

7 January 2021

Relaxation of isolated coronary arteries by angiotensin-converting enzyme inhibitors: role of endothelium-derived kinins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701281

7 January 2021

Ligand-induced cleavage of the V2 vasopressin receptor by a plasma membrane metalloproteinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701281

7 January 2021

Difference among angiotensin-converting enzyme inhibitors in potentiating effects on bradykinin-induced microvascular leakage in guinea pig airways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701281

7 January 2021

Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701281

7 January 2021

Comparative study on the mechanism of bradykinin potentiation induced by bradykinin-potentiating peptide 9a, enalaprilat and kinin-potentiating peptide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701281

7 January 2021

Co-solubilization of bradykinin B2 receptors and angiotensin-converting enzyme from guinea pig lung membranes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701281

7 January 2021

Converting enzyme inhibitors in cardiovascular therapy: current status and future potential

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701281

7 January 2021

Coronary vasodilation induced by captopril and zofenoprilat: evidence for a prostaglandin-independent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701281

7 January 2021

A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701281

7 January 2021

Endothelium dependent vasomotor responses to endogenous agonists are potentiated following ACE inhibition by a bradykinin dependent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701281

7 January 2021

Identifiers

DOI

10.1038/SJ.BJP.0701281

1 reference

14 October 2017

1 reference

14 October 2017

PubMed publication ID

9257930

1 reference